Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as this important UniSA research is awarded more than $2 million dollars under the National Health and Medical Research Council ( NHMRC ) 2021 Investigator Grants .

Professor Krasi Vasilev
Professor Krasi Vasilev

Led by international expert in biomedical and advanced materials, UniSA’s Prof Krasi Vasilev , the $2,738,220 NHMRC grant will help continue his vital work in anti-bacterial technologies for a range of medical devices, and build on his established successes in diagnostics and prognostics of diseases.

Prof Vasilev’s exemplary work in antibacterial technologies has seen him collaborate and conceive a range of innovations to improve the health of people around the world.

Notable commercial projects include a new non-invasive device for diagnostics of bladder cancer (with Motherson Innovations) and novel orthopaedic implants enhanced with antibacterial surfaces that substantially reduce the rate of infections associated with these devices (with Corin Group).

This work is delivering tangible outcomes for patients, medical professionals, and the Australian economy.

“Innovative technologies are the key to solving pressing medical and biological challenges, but it is only through valuable collaborations with clinicians and partnerships with industry that we are able to develop these technologies and take them to the next level,” Prof Vasilev says.

Image Credit: Adobe

News This Week